14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACHV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Tuesday for Achieve Life Sciences, Inc.
(Updated on Apr 23, 2024)

Sell candidate since Apr 22, 2024 Gain 2.04% PDF

The Achieve Life Sciences, Inc. stock price gained 2.04% on the last trading day (Tuesday, 23rd Apr 2024), rising from $4.41 to $4.50. During the last trading day the stock fluctuated 5.51% from a day low at $4.35 to a day high of $4.59. The price has risen in 5 of the last 10 days and is up by 3.21% over the past 2 weeks. Volume fell on the last day by -30 thousand shares and in total, 52 thousand shares were bought and sold for approximately $232.26 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.45% during the next 3 months and, with a 90% probability hold a price between $3.57 and $4.79 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACHV Signals & Forecast

The Achieve Life Sciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $4.48 and $4.49. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 25, 2024, and so far it has fallen -3.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Achieve Life Sciences, Inc. stock

Achieve Life Sciences, Inc. finds support from accumulated volume at $4.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.240 between high and low, or 5.51%. For the last week the stock has had daily average volatility of 4.56%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACHV) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Achieve Life Sciences, Inc. to open at $4.48, and during the day (based on 14 day Average True Range), to move between $4.29 and $4.71, which gives a possible trading interval of +/-$0.215 (+/-4.78%) up or down from last closing price. If Achieve Life Sciences, Inc. takes out the full calculated possible swing range there will be an estimated 9.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.42 (1.78%) than the resistance at $4.59 (2.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Achieve Life Sciences, Inc. stock A Buy?

Achieve Life Sciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.178 Sell Candidate Unchanged

Predicted Opening Price for Achieve Life Sciences, Inc. of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$4.48 ( 0.445%) $4.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACHV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.72 4.89 %
R2 4.63 2.85 %
R1 4.57 1.59 %
Current price: 4.50
Support S1 4.39 -2.48 %
S2 4.33 -3.74 %
S3 4.24 -5.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.14 14.22 %
R2 4.60 2.22 %
R1 4.59 2.00 %
Current price 4.50
Support S1 4.42 -1.78%
S2 4.35 -3.33%
S3 4.05 -10.00%

FAQ

What is the symbol for Achieve Life Sciences, Inc. Stock and on which exchange is it traded?
The symbol for Achieve Life Sciences, Inc. is ACHV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Achieve Life Sciences, Inc. Stock?
Achieve Life Sciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Achieve Life Sciences, Inc. Stock?
Achieve Life Sciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Achieve Life Sciences, Inc. Stock.

What's the current price of Achieve Life Sciences, Inc. Stock?
As of the end of day on the Apr 23, 2024, the price of an Achieve Life Sciences, Inc. (ACHV) share was $4.50.

What is the 52-week high and low for Achieve Life Sciences, Inc. Stock?
The 52-week high for Achieve Life Sciences, Inc. Stock is $10.25 and the 52-week low is $3.03.

What is the market capitalization of Achieve Life Sciences, Inc. Stock?
As of the Apr 23, 2024, the market capitalization of Achieve Life Sciences, Inc. is 154.134M.

When is the next earnings date for Achieve Life Sciences, Inc.?
The upcoming earnings date for Achieve Life Sciences, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Achieve Life Sciences, Inc.

Achieve Life Sciences. Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol.... ACHV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT